Evaxion Biotech AS (EVAX)
3.91
-0.26
(-6.24%)
USD |
NASDAQ |
May 01, 16:00
4.05
+0.14
(+3.58%)
Pre-Market: 20:00
Evaxion Biotech Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2022 | -23.79M |
March 31, 2022 | -26.08M |
December 31, 2021 | -21.93M |
September 30, 2021 | -22.24M |
Date | Value |
---|---|
June 30, 2021 | -18.71M |
March 31, 2021 | -13.52M |
December 31, 2020 | -12.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-26.08M
Minimum
Mar 2022
-12.44M
Maximum
Dec 2020
-19.82M
Average
-21.93M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Ascendis Pharma A/S | -505.97M |
DBV Technologies SA | -79.65M |
Cellectis SA | -24.75M |
Adaptimmune Therapeutics PLC | -140.88M |
Akari Therapeutics PLC | -- |